Solid tumor Trials in Jinan, China
Conditions / Solid tumor / Jinan, China
Solid tumor is a medical condition with active clinical research programs worldwide.
23 total trials for this combination
Showing top 10 of 23 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03944499 | Phase 1 Study of FS-1502 in Patients With HER2 Expressed Advanced Solid Tumors and Breast Cancer. | COMPLETED | PHASE1 |
| NCT04280081 | A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation | ACTIVE_NOT_RECRUITING | — |
| NCT06010342 | A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients | RECRUITING | — |
| NCT05642780 | SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT03774979 | SHR-1701 in Subjects With Metastatic or Locally Advanced Solid Tumors | UNKNOWN | PHASE1 |
| NCT06008288 | A Phase II Study Evaluating JAB-21822 Monotherapy in Adult Patients With Pancreatic Cancer and Other Solid Tumors Harboring the KRAS p.G12C Mutation. | RECRUITING | PHASE2 |
| NCT04930432 | Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors | RECRUITING | PHASE1/PHASE2 |
| NCT04679038 | A Trial of SHR-1701 in Combination With Famitinib in Patients With Advanced Solid Tumors | UNKNOWN | PHASE1/PHASE2 |
| NCT06873659 | SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors | RECRUITING | PHASE1 |
| NCT06016062 | A Study of RC148 As a Single Agent and Combination Therapy in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid Tumors | RECRUITING | PHASE1/PHASE2 |